Oligopeptides, representing B-and/or T-cell epitope(s) are promising candidates as future synthetic antigens for studying human autoimmune disorders. Synthetic peptides could be as efficient in inducing in vitro T-cell responses as recombinant proteins. We have studied desmoglein 3 (Dsg3) peptides representing T-cell epitope regions to determine their capability to induce in vitro T-cell response and to analyze the influence of their solution conformation.
Introduction
Desmogleins are cadherin type transmembrane adhesion proteins which form part of the core complex of desmosomes [1, 2] . These cell adhesion structures are present in large amount in tissues that are exposed to intense mechanical stress, including the epidermis and the heart muscle. Desmogleins are providing adhesion by the interaction with cadherins of the opposite cell. Inside the desmosome, these proteins are attached to the intercellular plaque proteins, e.g. desmoplakin, plakoglobin and plakophilin, which in turn interact with components of the cytoskeleton [3] . Therefore, desmosomes are essential for the integrity of the specific tissues.
Desmoglein 3 (Dsg3), a member of the cadherin superfamily, is the main target of Pemphigus vulgaris (PV), a very rare but life-threatening autoimmune blistering disorder [4, 5] . This disease affects the skin and mucous membranes and is caused by autoantibodies binding to distinct sites of the extracellular part of Dsg3, leading to gradually diminished cell-cell adhesion [6] [7] [8] [9] [10] . The production of pathogenic autoantibodies is organic part of the development of PV, but several other immunological processes are required prior to autoantibody induction.
Autoantigen specific T-cells play a crucial role in the initiation and progression of PV.
Activation of autoreactive CD 4+
T-cells depends on the autoantigen presentation by specific human leukocyte antigen (HLA) class-II alleles [11] [12] [13] [14] [15] expressed on antigen presenting cells (APC) such as dendritic cells, macrophages, and also B-cells. There is a positive feedback between B-cells and T-cells. Dsg3-specific T-cell response provides help to the B-cells to produce Dsg3-specific autoantibodies which bind to B-cell epitope regions [16, 17] of the Dsg3 protein antigen.
The present, clinically applied PV diagnostics are based on autoantibody recognition of the recombinant Dsg3 antigen [18] . Characterization of the binding sites (B-cell epitope regions) of PV autoantibodies has been extensively studied [16] [17] [18] [19] [20] [21] [22] . Identification and detailed analysis of the immunodominant T-cell epitope regions of Dsg3 also have an impact in understanding the immunopathology and development of the disease and in the design of future peptide based synthetic antigens. CD 4+ T-cells are also essential for induction of CD 8+ cytotoxic T-cell (CTL) responses through both cytokine secretion and dendritic cell sensitization. Specific HLA class-I alleles appear to be also involved in PV which mediates natural killer cell (NK) as well as CD 8+ CTL function [23] .
It is possible to determine T-cell epitope regions using synthetic peptides. Synthetic oligopeptides are as efficient in detecting in vitro T-cell responses as recombinant proteins.
The benefit of using epitope peptides is that they do not require and probably do not go through uptake and processing, and can be presented directly by HLA class I and II molecules [24] [25] [26] via peptide loading and exchange catalyzed by a specific HLA class II molecule.
HLA binding motifs with the use of peptide binding prediction methods (e.g. motif-and scoring matrix-based methods, artificial intelligence-based methods, structure-based methods) [27] may help in designing synthetic peptides, and in rationalizing their number. The fact that dominant epitopes frequently do not correspond to peptides which bind most tightly to HLA proteins [28] suggests that beside the appropriate amino acid composition for the binding motifs, the secondary structure can also affect the formation of 'HLA -synthetic peptide' complex and the recognition of this complex by the T-cell receptor.
Precise analysis of the immunodominant epitopes is important for the better understanding of the disease, and for the development of new diagnostics. There are several advantages of using synthetic epitope peptides in in vitro stimulation studies. Synthetic oligopeptides corresponding to the epitope regions of the immunodominant protein are obviously smaller molecules (from dodecamer to heptadecamer (12-17mer) synthetic peptides vs. cca 600 residues of the extracellular domain of the recombinant Dsg3 protein), therefore their production may be quicker, easier and more affordable, also the handling of the peptides is less problematic, e.g. the solubility and durability of the peptides is often better than that of larger molecules. regions. Small number of peptides can be synthesized manually or with synthesizer using solid phase techniques, and in case of a large number of peptides with Pepset technique [29] .
Alanine scanning is a useful tool to identify individual amino acid residues responsible for the activity of the peptide [30] . With truncated peptide libraries equimolar mixtures of N-or Cterminally truncated T-cell epitope peptide derivatives can be tested (e.g. 15-, 14-, 13-and 12-mer derivatives of the original epitope). After screening, the elements of the positive mixtures can be tested separately to identify the shortest amino acid sequence needed for activity, resulting in the removal of the unnecessary residues while preserving the essential ones [30] .
Alanine scanning is an effective approach also for studying the role of the flanking region amino acids [31] .
In some cases, the administration of oligopeptide epitopes does not elicit appropriate immune response [32] . In that case, to improve the immunogenicity of small peptides, the peptide sequence can be optimized by positional scanning, which means the substitution of an amino acid of interest with all other natural amino acids one at a time. Increase in activity identifies the preferred amino acid residues at the studied position [33] .
Although the mechanisms of CTL or helper T-cell induction by soluble antigens are not fully understood, features such as solubility, stability, and the conformation of the antigen, the affinity of binding to HLA class-I or -II molecules appear to be important for the induction of T-cell responses [34] [35] [36] .
Linear oligopeptides are expected to adopt multiple conformations in solution, in aqueous phase often unstructured, however, several studies to determine epitope regions using synthetic antigenic peptides assumed [35] or showed that the most potent T-cell and/or B-cell epitope peptides had tendency to form partially ordered structures in solution (authors applied various aqueous phases: water, PBS, 200 mM NaCl, water/TFE 9:1 v/v and non-aqueous phases: TFE, MeOH, ACN etc.) [36] [37] [38] [39] [40] . For instance in aqueous solution T-cell epitope peptides bearing β-turn structural elements [36] have been found besides the α-helical structure [37, 38] which was also found using the helix inducing solvent trifluoroethanol [39, 40] . These observations are suggesting that besides the linear sequence of the synthetic peptide antigen, the conformational preference in solution is also important in binding to proteins. The adopted conformation of synthetic T-cell epitope peptides in aqueous solution and the impact of conformation on the peptides' in vitro stimulating efficacy has not been studied widely.
Several theoretical and experimental tools exist for the analysis of the conformation of peptides. Using in silico predictions (e.g. Chou-Fasman secondary structure prediction, Garnier -Osguthorpe -Robson method, neural network methods (PSIPRED, JPRED), support vector machines, sequence covariation methods, etc.) the preferred conformation of the synthetic peptide can be determined [36, [41] [42] . Spectroscopic methods such as proton nuclear magnetic resonance (NMR), electronic circular dichroism (ECD) or Fourier transform infrared spectroscopy are applicable for the characterization of the conformational preferences of peptides in solution phase [36, [43] [44] [45] [46] . All spectroscopic methods sample a collection of peptide conformations, including unfolded forms as well. Therefore, the spectra are the manifestation of the population-weighted average of the spectra characteristic for the individual contributing structures.
The combination of in silico predictions, synthetic techniques and spectroscopic methods can be powerful tool for designing synthetic peptides as future antigens representing T-cell epitope regions.
In the past, for nearly two decades, several attempts have been made to determine T-cell epitope regions of the Dsg3 protein using some, but not all of the aforementioned methods [47] [48] [49] [50] As this brief review of literature on this topic shows: i) PV is difficult to systematically study because of the relatively small number (4-16) of accessible donors [47] [48] [49] [50] 52] . The difficulties are increased by stages of the disease in the different patients, different treatment, general condition of the patients, etc., ii) only few studies deal with structure -activity relationships using synthetic peptides as antigens [36] [37] [38] [39] [40] , iii) there are no highly specific antigens related to T-cell epitope regions which could be selectively applied to distinguish in vitro T-cell response between healthy donors and PV patients [47] [48] [49] [50] [51] [52] (Table 2 ). In our present study regions Dsg3/206-220 and Dsg3/762-776 [47] were represented by two new 17mer peptides (Dsg3/206-222 and Dsg3/761-777). These are elongated versions of the already published synthetic peptides [47] . In case of Dsg3/762-776 the elongation was necessary to avoid undesired side reactions on the peptide N-and Cterminus. N-terminally truncated derivatives of these peptides were also prepared ( Table 2 ).
The peptides were chemically characterized. The secondary structure of the selected regions of Dsg3 was predicted with Chou-Fasman algorithm, and the conformation of the 17mer peptides and their truncated derivatives was studied in solution by electronic circular dichroism spectroscopy (ECD). Solubility was determined in cell culture medium (aqueous phase). The in vitro cytotoxicity was determined by colorimetric tetrazolium (MTT) assay prior to the in vitro T-cell stimulating experiments. PBMCs -isolated from whole blood samples of PV patients and healthy donors -were stimulated with the synthetic peptides, and the IFN-γ content of supernatants was determined by a two-MoAb sandwich ELISA system.
A comparative analysis of these properties has to be carried out to prove the oligopeptides' applicability as synthetic antigens.
Materials and Methods

Chemicals and Reagents
Solid phase peptide synthesis, analysis and purification All amino acid derivatives and resins were purchased from Iris Biotech GmBH 
Synthesis of Dsg3 T-cell Epitope Region Peptide Series
Potential T-cell epitope peptides from the Dsg3 protein sequence and their N-terminally truncated derivatives (Table 2) 
Reverse Phase High-Performance Liquid Chromatography (RP-HPLC)
The crude products were purified on a KNAUER 2501 HPLC system (KNAUER, Berlin, Germany) using a semipreparative Phenomenex Jupiter C 18 column (250 mm x 10 mm) with 10 µm silica (300 Å pore size; Gen-Lab Ltd., Budapest, Hungary). Linear gradient elution 
Mass Spectrometry (MS)
Electrospray (ESI)-mass spectrometric analysis were carried out on an Esquire 3000+ ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany). Spectra were acquired in the 50 -2500 m/z range. Samples were dissolved in a mixture of 0.1% acetic acid in acetonitrile/H 2 O (50:50, v/v).
Amino Acid Analysis
Amino acid analysis was performed on Sykam Amino Acid S433H analyzer (Eresing, Germany) equipped with an ion exchange separation column and postcolumn derivatization.
Prior to analysis the peptides were hydrolyzed with 6 M HCl in sealed and evacuated tubes at 110°C for 24 h. For post-column derivatization the ninhydrin method was used.
Secondary Structure Prediction Analysis of Dsg3 T-cell Epitope Regions
The human Dsg3 (NCBI accession number: NP_001935.2, UniProt KB: P32926) sequence used for prediction was obtained from the protein sequence database [53, 54] [ showing three additional residues on both N-and C-termini.
Secondary Structure Determination of Dsg3 Peptides by Electronic Circular Dichroism (ECD)
ECD spectra were recorded using a Jasco 810 polarimeter (Jasco Corporation, Japan) in the λ = 180-300 nm wavelength range using a 0.02 cm path length quartz cell at room temperature, under constant nitrogen flush with continuous scanning mode. All spectra reported here were obtained as an average of five individual scan and corrected with the solvent ECD spectra.
The polarimeter was calibrated with ammonium α-10-camphor-sulfonate. The samples were 
PV Patients and Healthy Donors
Citrated/heparinated blood samples (14-18 mL) were obtained from three PV patients (Table   3) 
Determination of the in vitro Cytotoxic Effect of the Peptides Using MTT Assay
In vitro cytotoxic effect of the T-cell epitope region peptides was determined by MTT assay [57, 58] . PBMCs of a healthy control were divided into 96-well round-bottomed plate in 100
µL RPMI-1640 culture medium with an initial cell number of 2×10 
Results and Discussion
We have designed, synthesized and structurally characterized Dsg3 peptides representing four Table 2 ). The solubility, secondary structure in solution, as well as in vitro cytotoxicity of the peptides were determined. The in vitro T-cell stimulatory activity of these compounds was evaluated on PBMC isolated from healthy donors and PV patients. Comparative analysis was performed regarding the applicability of the oligopeptides as synthetic antigens.
Synthesis and Chemical Characterization of T-cell Epitope Peptide Series
All peptides were synthesized with Fmoc/tBu solid phase method using Rink Amide MBHA resin resulting in peptide amide N-terminus. After TFA cleavage, the crude products were purified by RP-HPLC. The characterization of the peptides by mass spectrometry and amino acid analysis confirmed the expected composition (Table 2 ).
Secondary Structure Prediction Analysis of Dsg3 T-cell Epitope Regions
In order to correlate solution conformation with in vitro biological activity, we have performed secondary structure prediction analysis of the Dsg3 regions corresponding to the 189-205, 206-222, 342-358, and 761-777 regions by Chou-Fasman approach [55] .
According to the prediction analysis data Dsg3 region 189-205 has a propensity to form a β-strand in the middle of the sequence (194) (195) (196) (197) (198) (199) , flanked by probable β-turns on both termini ( Figure 1A ). The Dsg3 region 206-222 has a slight preference for ordered, mostly β-strand structure broken with a β-turn in the middle of the sequence ( Figure 1B ), but the differences between the different conformational elements are small. Prediction analysis of 342-358 region shows that the N-terminal of the sequence may adopt β-strand or with lower probability α-helix conformation, while its C-terminus is probably in α-helical structure, according to the 7 residue long stretch (349-355) showing strong preference for this structure ( Figure 1C ). 761-777 region is most probably involved in forming several β-turn structures in the length of this sequence with unordered structure around residue 767 ( Figure 1D ).
Secondary Structure Determination of Dsg3 Peptides by Electronic Circular Dichroism
In order to validate the results of prediction analysis we have made an effort to determine experimentally the solution conformation of peptides described above by using ECD spectroscopy.
The secondary structures of peptides and proteins in solution can be determined with ECD spectroscopy. In solution the measured ECD curve is the sum of ECD of the different conformers. ECD spectra of the different secondary structures (ordered as periodic and aperiodic; and unordered conformations) are well documented. The ECD study of the peptides in water and TFE (α-helix promoting and membrane mimicking solvent) can help understanding the conformational stability and the solvent-sensitivity of peptides [75, 76] ; in addition, it can be useful at structure -function investigations.
The ECD curve of the α-helix has a broad negative band at λ ~ 222 nm (n-π* transition), a negative band at λ ~ 208 nm and a very intense positive band at λ ~ 192 nm (exciton couplet, π-π*) [61, 62] . ECD spectrum of a β-sheet has a negative band at λ ~ 215 nm (n-π* transition) with weaker intensity and a positive band at 195-200 nm (π-π* transition). Different turntypes can also be detected and distinguished by their characteristic chiral contributions. The ECD spectrum of a type I or III β-turn is similar to the α-helix spectrum (class C spectrum), but the band intensities are weaker, the π-π* bands are blue-shifted, while the n-π* bands are red-shifted [63] . Type II β-turns have similarity to the β-sheet spectrum, but the bands are redshifted by 5-10 nm, and an inverse γ-turn structure is characterized by a similar ECD shape [64] . ECD spectrum with an intensive negative band around λ ~ 200 nm and with a weak negative shoulder near λ ~ 230 nm can be interpreted as a random coil (U-type ECD shape).
Similar spectral features but with a weak positive shoulder at ~230 nm can be identified as polyproline type II helix (PPII) [65, 66] .
The conformation of Dsg3/189-205, Dsg3/206-222, Dsg3/342-358, and Dsg3/761-777 full length peptides and their truncated derivatives was characterized by ECD spectra recorded in TFE, water, and water/TFE mixture 1:1 (v/v) which solvents mimic the hydrogen bond stabilizing and destabilizing environments, respectively. ECD data are presented in Figure 2 and Table 4 , 5, and in the Supplementary Figure S1 -S5 and Table S1 . Changes in the spectra in different solvents can give information about the solvent-sensitivity and the conformational preference of the peptides. First we will summarize the spectroscopic features of the full length peptides, followed by the description of the truncated derivatives.
The ECD spectra of all full length peptides in TFE ( suggest the presence of 3 10 helix as well (Figure 2A ). Wavelength and intensity of band extrema, and intensity ratio of the negative π-π* and the n-π* bands are shown in Table 4 . stronger negative π-π* band at λ = 199 nm, and a weak but broad negative n-π* band (centralized at λ = 228 nm). This shape indicates the presence of unordered/PPII as dominant structure. These data emphasize that the secondary structures of the first three 17mer peptides are caused not only by the structure-inducing effect of the TFE, their ordered structure is relatively stable (their "solvent resistance" is higher than that of the fourth peptide).
The ECD spectra of the peptides in water ( Figure 2B , Table 4 (Table S1 , Figure S2A ).
In 50 % TFE-water solvent mixture ECD spectra were characterized by lower intensity bands and the blue-shifted band at λ max = 206 nm. These features indicate that in the conformer population unordered structural elements are present in a higher ratio, but the helical features of the spectra are also preserved (Table S1 , Figure S2B ). These data suggest that the solvent resistance of these peptides is relatively high; in the 50% solvent still the ordered structure dominates. All truncated peptides show the same ECD spectrum in water (a strong negative band at 195-200 nm which is accompanied by a shoulder at λ ~ 230 nm), which reflects their unordered structure (Table S1 , Figure S2C ). The ECD results in TFE are in good agreement with the Chou-Fasman prediction, which shows mainly β-structures (β-sheet and isolated β-turns) ( Figure 1A ).
In TFE and 50% TFE/water mixture the conformer population of the truncated derivatives of Dsg3/206-222 and Dsg3/342-358 peptides are very similar: mainly α-helices (in TFE ~60% and ~50%) (Table S1 ; Figure S3A , S4A). However, analyzing the spectra of the shortest peptide from the Dsg3/342-358 series (Dsg3/347-358) the low intensity bands and the C-type ECD shape indicate the presence of mainly β-turns (probably βI(III) turns) apart from unordered conformational elements.
In 50% TFE/water 1:1 v/v as solvent the ratio of the unordered conformers has increased (Table S1 , FigureS3B, S4B) as expected. In water Dsg3/206-222 peptide series shows a typical U-type ECD shape which indicates that mostly the unordered structures dominate.
( Table S1 , FigureS3C, S4C). Peptide series Dsg3/342-358 shows similar features, but the weak negative band at λ ~ 225 nm red shifted compared to the full length peptide. In case of Dsg3/342-358 peptide the band intensity at λ ~ 200 nm significantly decreased. Based on the results of Shanmugam and Polaravapu [77] , this type of spectrum shows a significant contribution of PPII-type conformation (a mixture of unordered and PPII conformations).
According to the prediction data in both peptide series periodical ordered structure dominates.
Next the Dsg3/761-777 series was analyzed. In TFE the truncated derivatives of Dsg3/761-777 full length peptide show lower intensity ECD spectra, compared to the intensity of the spectra of other peptide series. This fact indicates lower helical content of the conformer population: mainly α-helical structure was observed besides unordered structure elements (Table 5 , Figure 2C ). The shortest Dsg3/766-777 peptide shows typical C-type curve reflecting the presence of β-turn conformers (β-I(III) besides unordered structures. In TFEwater mixture all peptides from this series have U-type ECD curves with low intensity (Table   5 , Figure 2D ) and weaker negative bands at 225-231 nm. The higher ratio of unordered conformers besides ordered conformers (mainly turns) indicates higher backbone flexibility.
The unordered structure ratio is much higher compared to any other peptide series (Table 5 , Figure 3 show that the peptide remains intact under these conditions, for the other peptides data are not shown.
The in vitro cytotoxic effect of the 17mer peptides and their N-terminally truncated derivatives on PBMC cells isolated from healthy blood donors was studied at various concentrations (0.5, 5.0, 50, and 500 µM) using MTT assay. Data are summarized in Table 2 .
Dsg3/342-358 and Dsg3/345-358 peptides have shown cytotoxicity in vitro at 252 µM and 290 µM IC 50 value, respectively. The other peptides had no cytotoxic effect in vitro even at the highest concentration (500 µM) after overnight incubation.
PBMCs isolated from three PV patients (Table 3) 
